TERMINAL DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA CELL LINE, HL-60, IN THE ABSENCE OF CELL PROLIFERATIONFERRERO D; TARELLA C; GALLO E et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 11; PP. 4421-4426; BIBL. 33 REF.Article

FACTORS THAT AFFECT HUMAN HEMOPOIESIS ARE PRODUCED BY T-CELL GROWTH FACTOR DEPENDENT AND INDEPENDENT CULTURED T-CELL LEUKEMIA-LYMPHOMA CELLSTARELLA C; RUSCETTI FW; POIESZ BJ et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 6; PP. 1330-1336; BIBL. 34 REF.Article

INDUCTION OF DIFFERENTIATION OF HL-60 CELLS BY DIMETHYL SULFOXIDE: EVIDENCE FOR A STOCHASTIC MODEL NOT LINKED TO THE CELL DIVISION CYCLETARELLA C; FERRERO D; GALLO E et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 2; PP. 445-449; BIBL. 29 REF.Article

T-CELL GROWTH BACTOR AND THE ESTABLISHMENT OF CELL LINES FROM HUMAN T-CELL NEOPLASIASRUSCETTI FW; POIESZ BJ; TARELLA C et al.1982; PROG. CANCER RES. THER.; ISSN 0145-3726; USA; DA. 1982; VOL. 23; PP. 153-166; BIBL. 43 REF.Article

Functional and phenotypic characterization of two HL60 clones resistant to dimethylsulfoxideFERRERO, D; GALLO, E; LANFRANCONE, L et al.Experimental cell research. 1983, Vol 147, Num 1, pp 111-118, issn 0014-4827Article

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilizationTARELLA, C; DI NICOLA, M; PILERI, A et al.Bone marrow transplantation (Basingstoke). 2002, Vol 30, Num 11, pp 725-732, issn 0268-3369, 8 p.Article

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma : evidence for a role of both chemotherapy and rituximab infusionMAGNI, M; DI NICOLA, M; PILERI, A et al.Blood. 2000, Vol 96, Num 3, pp 864-869, issn 0006-4971Article

A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantationFERRERO, D; TARELLA, C; CHERASCO, C et al.Bone marrow transplantation (Basingstoke). 1998, Vol 21, Num 4, pp 409-413, issn 0268-3369Article

Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse : comparison with patients at diagnosis and impact on clinical outcomeTARELLA, C; CASTELLINO, C; CHERASCO, C et al.British journal of haematology. 1997, Vol 99, Num 1, pp 41-46, issn 0007-1048Article

Multiple myeloma : reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesOMEDE, P; TARELLA, C; TRIOLO, S et al.British journal of haematology. 1997, Vol 99, Num 3, pp 685-691, issn 0007-1048Article

Purging procedures for acute leukaemias in autologous BMTRIZZOLI, V; MANGONI, L; DE LAURENZI, A et al.Bone marrow transplantation (Basingstoke). 1989, Vol 4, pp 77-80, issn 0268-3369, 4 p., suppl. 4Conference Paper

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo OsseoOLIVIERI, A; MARCHETTI, M; LEMOLI, R et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 3, pp 342-351, issn 0268-3369, 10 p.Article

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support : a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)TARELLA, C; ZANNI, M; STELLA, M et al.Leukemia. 2007, Vol 21, Num 8, pp 1802-1811, issn 0887-6924, 10 p.Article

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patientsRICCA, I; ROCCI, A; CALVI, R et al.Leukemia. 2007, Vol 21, Num 4, pp 697-705, issn 0887-6924, 9 p.Article

Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patientsPALUMBO, A; TRIOLO, S; ARGENTINO, C et al.Blood. 1999, Vol 94, Num 4, pp 1248-1253, issn 0006-4971Article

High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaGIANNI, A. M; BREGNI, M; VALAGUSSA, P et al.The New England journal of medicine. 1997, Vol 336, Num 18, pp 1290-1297, issn 0028-4793Article

Haematological support of high-dose sequential chemotherapy : clinical evidence for reduction of toxicity and high response rates in poor risk lymphomasTARELLA, C; GAVAROTTI, P; CARACCIOLO, D et al.Annals of oncology. 1995, Vol 6, Num 4, pp 3-8, issn 0923-7534, SUPArticle

Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxinBENEDETTI, G; BONDESAN, P; CARACCIOLO, D et al.Experimental hematology. 1994, Vol 22, Num 2, pp 166-173, issn 0301-472XArticle

High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myelomaGIANNI, A. M; TARELLA, C; PILERI, A et al.Journal of clinical oncology. 1994, Vol 12, Num 3, pp 503-509, issn 0732-183XArticle

Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cellsGIANNI, A. M; TARELLA, C; SIENA, S et al.Bone marrow transplantation (Basingstoke). 1990, Vol 6, Num 2, pp 143-145, issn 0268-3369, 3 p.Article

Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activityLANFRANCONE, L; FERRERO, D; GALLO, E et al.Journal of cellular physiology. 1985, Vol 122, Num 1, pp 7-13, issn 0021-9541Article

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantationCORRADINI, P; TARELLA, C; ZALLIO, F et al.Leukemia. 2006, Vol 20, Num 9, pp 1533-1538, issn 0887-6924, 6 p.Article

Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: Non-Hodgkin's lymphomaZALLIO, F; CUTTICA, A; TARELLA, C et al.Annals of hematology (Print). 2002, Vol 81, Num 8, pp 448-453, issn 0939-5555Article

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaLADETTO, M; ZALLIO, F; BONDESAN, P et al.Leukemia. 2001, Vol 15, Num 12, pp 1941-1949, issn 0887-6924Conference Paper

Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas : a critical reappraisal of molecular strategiesCORRADINI, P; LADETTO, M; PILERI, A et al.Leukemia. 1999, Vol 13, Num 11, pp 1691-1695, issn 0887-6924Conference Paper